Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04217122 · ClinicalTrials.gov registry record · NA

Effect of Strawberry Consumption on the Microbiome

A NA study of Microbiome, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT04217122 is a NA study of Microbiome that has completed, run by University of California, Los Angeles. The registered enrollment target is 30 participants, below the 140-participant average among 12 other Microbiome trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04217122, a NA study of Microbiome, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This pilot study will assess the ability of daily consumption of two servings of California strawberries to alter gut microbiome composition, leading to increased bile secretion and decreased plasma cholesterol in a free-living population.

Conditions Studied

Interventions

  • OTHER strawberry powder
  • OTHER placebo powder

Study Locations (1)

California

  • UCLA Center for Human Nutrition, 1000 Veteran Ave. - Los Angeles

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2018-09-11
Est. Completion 2019-12-19
Phase NA

What the Registry Record Tells You About NCT04217122

The ClinicalTrials.gov registry entry for NCT04217122 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 140-participant average among 12 other Microbiome trials with a reported enrollment target (79% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Microbiome appearing as the primary indexed condition, and to 2 interventions - of which strawberry powder is the first listed.

NCT04217122 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04217122 about?

NCT04217122 is a clinical study titled "Effect of Strawberry Consumption on the Microbiome". This pilot study will assess the ability of daily consumption of two servings of California strawberries to alter gut microbiome composition, leading to increased bile secretion and decreased plasma cholesterol in a free-living population.

What is the current status of trial NCT04217122?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-09-11. Estimated completion is 2019-12-19.

What conditions does trial NCT04217122 study?

This clinical trial studies the following conditions: Microbiome.

What interventions are being tested in trial NCT04217122?

The interventions under investigation include: strawberry powder (OTHER), placebo powder (OTHER).

Who is sponsoring clinical trial NCT04217122?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04217122 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Microbiome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.